10-Q: SunHydrogen Reports Q3 Loss, Boosts R&D Amid Green Hydrogen Push

SunHydrogen, Inc. reported a reduced net loss of $1.56 million for Q3 2025, driven by increased R&D and administrative costs, while continuing its focus on green hydrogen technology development.

Summary

• Net loss for the three months ended September 30, 2025, was $1,559,778, a decrease from $2,046,838 in the prior year period.
• Revenue for the quarter was $1,250, compared to $0 in the same period last year, primarily from related-party consulting services.
• Operating expenses significantly increased to $1,924,395 from $1,036,427 year-over-year, mainly due to higher research and development costs ($1,198,719 vs $608,005) and general and administrative expenses ($705,977 vs $418,744).
• Cash and cash equivalents decreased to $33,465,159 as of September 30, 2025, from $34,628,625 as of June 30, 2025.
• Working capital surplus decreased by $2,270,208 to $34,778,471 as of September 30, 2025.
• The company repurchased and cancelled 1,486 shares of Series C Preferred Stock for $1,000,000 during the quarter.
• Investment in TECO 2030 ASA was written down to $0 due to bankruptcy and delisting, but the company received 39,350,000 shares in Newco, a private entity, which is also valued at $0 due to no readily determinable fair value.

Sentiment

Score: 3

Explanation: The company reported a reduced net loss, but this was largely due to the absence of a prior-year investment impairment, not improved operational profitability. Operating expenses and cash burn from operations significantly increased. The company continues to rely heavily on external capital for its going concern, and disclosed a material weakness in internal controls. While R&D investment is positive for future prospects, the current financial health and operational cash flow are concerning.

Positives

• Net loss decreased to $1.56 million in Q3 2025 from $2.05 million in Q3 2024.
• Generated $1,250 in revenue from consulting services in Q3 2025, compared to no revenue in Q3 2024.
• Cash and cash equivalents remain substantial at $33.47 million as of September 30, 2025.
• The company continues to invest significantly in research and development, with R&D costs increasing to $1.20 million in Q3 2025 from $0.61 million in Q3 2024.
• Successfully repaid the $211,750 loan from the CEO.

Negatives

• Operating expenses increased significantly by $887,968 year-over-year, primarily driven by R&D and G&A.
• Cash used in operating activities increased to $1.19 million in Q3 2025 from $0.70 million in Q3 2024, indicating a higher cash burn.
• Cash and cash equivalents decreased by $1.16 million during the quarter.
• Working capital surplus decreased by $2.27 million during the quarter.
• The company's investment in TECO 2030 ASA was completely impaired to $0 due to bankruptcy and delisting.
• Accumulated deficit increased to $101.64 million as of September 30, 2025.
• Disclosure controls and procedures were deemed not effective due to a material weakness related to segregation of duties.

Risks

• Ability to continue as a going concern is dependent upon raising capital through financing transactions and future revenue.
• No assurance that the company will be able to continue raising the required capital on acceptable terms, or at all.
• If unable to obtain sufficient funds, the company may be forced to curtail and/or cease operations.
• Material weakness in disclosure controls and procedures due to inherent segregation of duties issues in a small company.
• Reliance on estimates and assumptions in financial reporting, which could differ from actual results.
• Concentration risk with cash balances in excess of FDIC limits ($31,837,838 as of September 30, 2025).

Future Outlook

The company is committed to replacing fossil fuel-derived hydrogen with renewable hydrogen, developing both nanoparticle-based and thin-film solar cell methodologies. It aims for a target cost of $2.50/kg for its technology, aspiring to be cost-competitive with brown hydrogen and below clean hydrogen competitors. Management believes it will be able to continue raising capital to support operations and core business development, but acknowledges there is no assurance of securing required funding.

Management Comments

• Our core mission remains the replacement of fossil fuel-derived hydrogen with renewable hydrogen.
• We believe our technology has the potential to be one of – if not the most – economical green hydrogen solutions.
• We believe our solution has the potential to clear a path for renewable hydrogen to compete with natural gas hydrogen and gain mass market acceptance as a true replacement for fossil fuels.
• Our ability to continue as a going concern is dependent upon raising capital through financing transactions and future revenue.
• Management believes that the Company will be able to continue to raise funds through the sale of its securities to its existing shareholders and prospective new investors, which will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the Company to continue to develop its core business.
• There can be no assurance that we will be able to continue raising the required capital for our operations on terms and conditions that are acceptable to us, or at all.
• If we are unable to obtain sufficient funds, we may be forced to curtail and/or cease our operation.
• Management believes that the financial statements included in this report fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented, despite a material weakness in internal controls.

Industry Context

SunHydrogen operates in the rapidly evolving green hydrogen sector, aiming to disrupt traditional fossil fuel-derived hydrogen production. Its technology, which uses sunlight and water, positions it as a potential low-cost producer, targeting $2.50/kg to compete with 'brown hydrogen' and undercut other clean hydrogen methods. The dual approach of nanoparticle technology and leveraging mature thin-film solar manufacturing platforms suggests a strategy to accelerate market entry and achieve scalability in a competitive and capital-intensive industry focused on decarbonization.

Comparison to Industry Standards

• The company targets a cost of $2.50/kg for its renewable hydrogen, aiming to be cost-competitive with brown hydrogen (produced from natural gas) and below the cost of other clean hydrogen competitors.
• Its nanoparticle technology is designed to directly use electrical charges from sunlight, avoiding reliance on grid power or costly power electronics common in conventional electrolyzers.
• The planned scalable system configuration of many individual hydrogen-generating panels is intended to ensure redundancy, security, and stability, differentiating it from potentially less fault-tolerant systems.
• The parallel development utilizing commercially available, mass-produced thin-film solar cells and modules aims to leverage an established manufacturing platform for potentially faster market entry, a strategy often employed by companies seeking to accelerate commercialization in nascent industries.

Management Changes

Corporate Governance

Legal Proceedings

• The company is not currently a party to, nor is any of its property currently the subject of, any material legal proceeding.

Related Party Transactions

• Generated $1,250 in revenue from consulting services with a related party during the three months ended September 30, 2025.
• The $211,750 loan from the CEO for repayment of accrued salary expense was fully repaid as of September 30, 2025.
• Investment in TECO 2030 ASA (where CEO Timothy Young was a director) was impaired to $0 due to bankruptcy and delisting.
• Received 39,350,000 shares in Newco (a subsidiary of TECO HOLDING AS) through a share allocation agreement, with SunHydrogen's Director of Business Operations, Hans-Peter Klein, appointed to Newco's board.

Stakeholder Impact

• Shareholders: Potential for significant dilution from future capital raises, as the company is dependent on external funding. The repurchase of Series C preferred shares reduced the number of convertible preferred shares, but the total potential common shares from options, warrants, and remaining preferred shares is substantial. The material weakness in internal controls could impact investor confidence.
• Employees: Stock-based compensation is a significant component, with $1.3 million of unrecognized compensation cost expected to be recognized over 0.6 years.
• Customers: Minimal revenue from related-party consulting services, indicating limited customer base currently.
• Suppliers/Research Partners: Ongoing research agreements with universities (Iowa, Michigan, Texas at Austin) indicate continued collaboration and financial commitments.
• Creditors: The company's going concern status is dependent on future capital raises, which could impact creditors if funding is not secured.

Next Steps

• Continue development of nanoparticle-based hydrogen generators.
• Continue development of the new methodology utilizing thin-film solar cells and proprietary hydrogen module design.
• Continue research agreements with the University of Iowa (through Sep 30, 2025), University of Michigan (through Sep 30, 2026), and University of Texas at Austin (through June 30, 2026).
• Address the material weakness in disclosure controls and procedures, relying on management review and an outside financial consultant.
• Seek to raise additional capital through the sale of securities to meet obligations and continue business development.

Key Dates

Recommendation

While SunHydrogen reported a reduced net loss and continues to invest heavily in R&D for promising green hydrogen technology, its operational cash burn has increased, and it remains entirely dependent on external capital to continue as a going concern. The material weakness in internal controls is a governance concern. The impairment of the TECO investment highlights the high-risk nature of early-stage clean tech investments. The company's long-term potential in the green hydrogen market is significant, but the immediate financial challenges and reliance on future capital raises suggest a 'hold' position for existing investors, awaiting clearer signs of commercialization progress and sustainable funding, while new investors should exercise extreme caution due to the high risk profile.

Keywords

Green Hydrogen, Renewable Energy, Hydrogen Production, Solar Hydrogen, Nanoparticle Technology, Clean Technology, SEC Filing, 10-Q, Energy Innovation, Water Splitting